Field Applications Scientist Gyros Protein Technologies Lakewood, Colorado
Description: Antibody–drug conjugates (ADC) are a revolutionary class of targeting therapeutics, especially within oncology. The complex structure of ADC comes with unique analytical challenges, including need for multiple assays and specialized reagents to measure biological samples with a throughput that meets drug discovery time lines. We will present real-world case studies showing how analytical challenges are successfully addressed by implementing automated immunoassays in ADC drug development.
Learning Objectives:
Get insight into how the hybrid structure of ADCs requires multi-analyte assessment in beyond traditional antibody bioanalysis
Discover how automated immunoassay platforms address critical bottlenecks of ADC development, such as rapid selection of antibody pairs, matrix interference, and sample consumption
Learn from real-world case studies how CROs and biopharmaceutical organizations use automated immunoassays to successfully tackle complex ADC bioanalysis
